Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 27, 2018 07:00 ET | Source: Midatech Pharma Plc

Midatech Announces Proposed Sale of Midatech Pharma US Inc. (“MTP US”) to Kanwa Holdings, LP an affiliate of Barings LLC

27 September 2018 Midatech Pharma PLC ("Midatech" or the "Company") Midatech Announces Proposed Sale of Midatech Pharma US Inc. (“MTP US”) to Kanwa Holdings, LP an affiliate of Barings LLC Total...
August 31, 2018 07:00 ET | Source: Midatech Pharma Plc

Midatech Announces Interim Results from Proof of Concept Exploratory Study for its MTD201 Q-Octreotide Programme and Q-Sphera™ Microsphere Technology

31 August 2018 Midatech Pharma PLC("Midatech" or the "Company") Midatech Announces Interim Results from Proof of Concept Exploratory Study for its MTD201 Q-Octreotide Programme and Q-Sphera™...
July 23, 2018 07:11 ET | Source: Midatech Pharma Plc

Midatech Pharma US announces Co-Promotion Agreement with Bausch Health Companies Inc. for the Exclusive Right to Promote NeutraSal® to the Oncology Market in United States

23 July 2018 Midatech Pharma PLC(“Midatech”, “Company” or “Group”) Midatech Pharma US announces Co-Promotion Agreement with Bausch Health Companies Inc. for the Exclusive Right to Promote NeutraSal®...
May 18, 2016 02:00 ET | Source: Midatech Pharma PLC

Midatech Pharma announces clinical pipeline update

ABINGDON, England, May 18, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialising and developing products...
May 11, 2016 12:44 ET | Source: Midatech Pharma PLC

Result of Annual General Meeting

ABINGDON, England, May 11, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialising and developing products...
April 26, 2016 02:00 ET | Source: Midatech Pharma PLC

Midatech Pharma announces positive pharmacokinetic data with Q-Octreotide

ABINGDON, England, April 26, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH; Nasdaq:MTP), the international specialty pharmaceutical company focused on commercialising and developing products in...
April 21, 2016 02:00 ET | Source: Midatech Pharma PLC

Midatech achieves positive dosing data for OpsiSporin Uveitis programme

ABINGDON, England, April 21, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH) (Nasdaq:MTP), the international specialty pharmaceutical company focused on commercialising and developing products...
April 13, 2016 02:00 ET | Source: Midatech Pharma PLC

Midatech Pharma PLC (“Midatech” or the “Company”) Audited financial results for the year ended 31 December 2015

Midatech will host a conference call and live Q&A session today (Wednesday 13 April 2016) at 1300 BST / 0800 EDT for analysts and investors to discuss the Annual Results. Dr Jim Phillips, Chief...
April 11, 2016 02:00 ET | Source: Midatech Pharma PLC

Midatech’s Commercial Launch of Zuplenz® (Ondansetron) Oral Soluble Film to Prevent Post-Operative, Chemotherapy and Radiation-Induced Nausea and Vomiting in US

ABINGDON, England, April 11, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH); (Nasdaq:MTP), the international specialty pharmaceutical company focused on commercialising and developing...